Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

Artificial intelligence in medicine regulation

Regulators may need to apply a risk-based approach to assessing and regulating AI, which could be informed through exchange and collaboration in ICMRA.

Falsified Remdesivir identified in WHO region of the Americas

WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products.

FDA Authorizes Additional COVID-19 Vaccine Dose for Certain Immunocompromised Individuals

The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna Vaccines and determined that the administration of third vaccine doses may increase protection in this population.

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs

The Solidarity PLUS trial is a platform trial that represents the largest global collaboration among WHO Member States.

Recommendations on common technical denominators for track and trace systems

The extensive and helpful feedback was carefully analysed and reviewed in order to refine and finalise the recommendations on common technical denominators for track and trace systems.

WHO revises guidance on GMPs for investigational products and R&D facilities

WHO said the objective of the update is to align the guidance with “current expectations and trends in good manufacturing practices”.
spot_img

Expert Articles

spot_img